Chemoradiation Followed by Durvalumab in Poor Risk and/or Elderly Patients With Stage III NSCLC
Condition(s):Stage III Non-small-cell Lung CancerLast Updated:September 11, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Stage III Non-small-cell Lung CancerLast Updated:September 11, 2023Recruiting
Condition(s):Bladder CancerLast Updated:March 23, 2022Unknown status
Condition(s):HIV; CancerLast Updated:May 5, 2022Completed
Condition(s):Mesothelioma; Pleural MesotheliomaLast Updated:July 5, 2023Completed
Condition(s):Esophageal CancerLast Updated:September 25, 2023Completed
Condition(s):Esophageal Squamous Cell CarcinomaLast Updated:August 13, 2019Unknown status
Condition(s):Small Cell Lung Cancer (SCLC)Last Updated:June 7, 2022Completed
Condition(s):Colorectal Cancer; Solid TumorLast Updated:April 21, 2023Terminated
Condition(s):Non Small Cell Lung Cancer; Renal Cell CarcinomaLast Updated:November 17, 2020Withdrawn
Condition(s):Rectal CancerLast Updated:April 20, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.